According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is ยฃ0.23. In 2024 the company made an earnings per share (EPS) of -ยฃ0.77 an increase over its 2023 EPS that were of -ยฃ1.98.